Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aaron S. Parker"'
Autor:
Hanna Stedt, Laura Alasaarela, Haritha Samaranayake, Jere Pikkarainen, Ann-Marie Määttä, Ivana Kholová, Aaron S. Parker, Seppo Ylä-Herttuala
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 1, Iss C (2012)
Malignant glioma is a severe cancer with a poor prognosis. Local occurrence and rare metastases of malignant glioma make it a suitable target for gene therapy. Several studies have demonstrated the importance of Src kinase in different cancers. Howev
Externí odkaz:
https://doaj.org/article/8d8aa55ba88c44d9a10476015d1c6dcf
Publikováno v:
Immunological Reviews. 246:239-253
Autor:
Jere Pikkarainen, Ann-Marie Määttä, Hanna Stedt, Laura Alasaarela, Seppo Ylä-Herttuala, Aaron S. Parker, Haritha Samaranayake, Ivana Kholová
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 1, Iss C (2012)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Malignant glioma is a severe cancer with a poor prognosis. Local occurrence and rare metastases of malignant glioma make it a suitable target for gene therapy. Several studies have demonstrated the importance of Src kinase in different cancers. Howev
Autor:
Angel Raya, W. Travis Berggren, Aaron S. Parker, Fred H. Gage, Amy L. Firth, Margaret Lutz, Juan Carlos Izpisua Belmonte, Kristen J. Brennand, Niels-Bjarne Woods, Roksana Moraghebi, Inder M. Verma
Publikováno v:
Stem cells (Dayton, Ohio). 29(7)
By mimicking embryonic development of the hematopoietic system, we have developed an optimized in vitro differentiation protocol for the generation of precursors of hematopoietic lineages and primitive hematopoietic cells from human embryonic stem ce
Autor:
Roksana Moraghebi, Niels-Bjarne Woods, Aaron S. Parker, Andreas Herbst, Roger Emanuel Rönn, Claudia Stolz, Inder M. Verma, Patricia Chaves Guerrero, Marcus Larsson, Ewa Sitnicka
Publikováno v:
Blood. 118:1285-1285
Abstract 1285 Identifying the key regulatory genes that direct human ES/iPS cell differentiation to certain lineages is required before considering these cells for their potential clinical application. It has been proposed that the cellular starting
Autor:
Roger Emanuel Rönn, Margaret Lutz, Niels-Bjarne Woods, Travis Berggren, Aaron S. Parker, Roksana Moraghebi
Publikováno v:
Blood. 116:2628-2628
Abstract 2628 The ability to generate hematopoietic stem cells (HSC's) from patient derived induced pluripotent stem (iPS) cells, would enable the generation of an unlimited supply of HLA matched transplantable cells for the treatment of both hematol
Autor:
Margaret Lutz, Aaron S. Parker, Niels-Bjarne Woods, Travis Berggren, Roksana Moraghebi, Roger Emanuel Rönn
Publikováno v:
Blood. 116:4790-4790
Abstract 4790 The ability to generate hematopoietic stem cells (HSCs) from an unlimited source of cells, such as from patient derived induced pluripotent stem (iPS) cells, would enable the generation of an unlimited supply of HLA matched transplantab